Automating cell therapy manufacturing without redesigning established workflows

As cell therapy programs transition into clinical development, manufacturing teams face increasing pressure to automate workflows while preserving biological performance and hard-earned process knowledge. Many teams hesitate to introduce automation due to concerns around forced process redesign, loss of flexibility, or risks to clinical timelines.

In this webinar, Cytiva specialists will demonstrate how the Sefia™ cell therapy manufacturing platform enables closed, automated processing without requiring changes to existing media, reagents, or core process logic. Using real workflow learnings and development examples, the speakers will explore how automation can be introduced incrementally to support clinical readiness today while preparing for future scale.

Attendees will gain practical guidance on mapping their current workflows to an automation-ready platform, reducing operational risk, and building a clear path from development to GMP manufacturing.

Key learning objectives:

Understand how to automate cell therapy workflows without redesigning biology
Identify platform features that support clinical readiness and future scale
Learn how closed, modular systems reduce operational risk while preserving flexibility